1 April 2018 Listing of PrEP on PBS

The EPIC-NSW management team welcomes the announcement by the Commonwealth Health Minister of the listing of co-formulated tenofovir and emtricitabine for PrEP on the Pharmaceutical Benefits Scheme from 1st April 2018.

The EPIC-NSW management team will be in touch with each EPIC-NSW clinic in the coming weeks with more details about transitional arrangements. Please continue to dispense study medication and enrol new eligible high-risk participants as normal. It is important that EPIC-NSW participants understand that they should continue to take their study PrEP medication as usual.